Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease

Kate Kosmac, Ahmed Ismaeel, Daniel B. Kim-Shapiro, Mary M. McDermott*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)49-51
Number of pages3
JournalCirculation research
Volume132
Issue number1
DOIs
StatePublished - Jan 6 2023

Funding

M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge. M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.

Keywords

  • Editorials
  • cilostazol
  • disability
  • nitric oxide
  • peripheral artery disease
  • revascularization
  • therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology

Cite this